Prince Akwasi Mensah

Array ( [id] => 3035144 [patent_doc_number] => 05300517 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-04-05 [patent_title] => 'Piperidine compounds having anti-acetylcholinesterase activity' [patent_app_type] => 1 [patent_app_number] => 8/053202 [patent_app_country] => US [patent_app_date] => 1993-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16707 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/300/05300517.pdf [firstpage_image] =>[orig_patent_app_number] => 053202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3034672 [patent_doc_number] => 05376362 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-12-27 [patent_title] => 'Antiperspirant-deodorant cosmetic products' [patent_app_type] => 1 [patent_app_number] => 8/053836 [patent_app_country] => US [patent_app_date] => 1993-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4629 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/376/05376362.pdf [firstpage_image] =>[orig_patent_app_number] => 053836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3416463 [patent_doc_number] => 05393756 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-02-28 [patent_title] => '5H-[1,2]benzisothiazolo[2,3-a]quinoline-5-ones and analogs as antiinflammatory agents' [patent_app_type] => 1 [patent_app_number] => 8/051611 [patent_app_country] => US [patent_app_date] => 1993-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17173 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1457 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/393/05393756.pdf [firstpage_image] =>[orig_patent_app_number] => 051611 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3110285 [patent_doc_number] => 05414001 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-05-09 [patent_title] => 'Antineoplastic pyrrolo[4,3,2-de]quinolin-8(1H)-ones' [patent_app_type] => 1 [patent_app_number] => 8/048441 [patent_app_country] => US [patent_app_date] => 1993-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21554 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/414/05414001.pdf [firstpage_image] =>[orig_patent_app_number] => 048441 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3037585 [patent_doc_number] => 05300645 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-04-05 [patent_title] => 'Tetrahydro-pyrido-indole' [patent_app_type] => 1 [patent_app_number] => 8/048392 [patent_app_country] => US [patent_app_date] => 1993-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16859 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 308 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/300/05300645.pdf [firstpage_image] =>[orig_patent_app_number] => 048392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3123915 [patent_doc_number] => 05436239 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-07-25 [patent_title] => 'Method of treating clostridium difficile colitis and cholera' [patent_app_type] => 1 [patent_app_number] => 8/040444 [patent_app_country] => US [patent_app_date] => 1993-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 3719 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/436/05436239.pdf [firstpage_image] =>[orig_patent_app_number] => 040444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2986481 [patent_doc_number] => 05266573 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-11-30 [patent_title] => 'Trifluoromethylphenyltetrahydropyridines for the treatment and/or prophylaxis of intestinal motility disorders' [patent_app_type] => 1 [patent_app_number] => 8/038082 [patent_app_country] => US [patent_app_date] => 1993-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2159 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/266/05266573.pdf [firstpage_image] =>[orig_patent_app_number] => 038082 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3567279 [patent_doc_number] => 05484788 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-01-16 [patent_title] => 'Buspirone as a systemic immunosuppressant' [patent_app_type] => 1 [patent_app_number] => 8/037271 [patent_app_country] => US [patent_app_date] => 1993-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6811 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/484/05484788.pdf [firstpage_image] =>[orig_patent_app_number] => 037271 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3449272 [patent_doc_number] => 05424322 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-06-13 [patent_title] => 'A personality disorder treatment method and composition' [patent_app_type] => 1 [patent_app_number] => 8/038427 [patent_app_country] => US [patent_app_date] => 1993-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6561 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/424/05424322.pdf [firstpage_image] =>[orig_patent_app_number] => 038427 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3050363 [patent_doc_number] => 05283230 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-02-01 [patent_title] => '5-heterocyclic 2-(2-imidazolin-2-yl)-pyridines as herbicides' [patent_app_type] => 1 [patent_app_number] => 8/036120 [patent_app_country] => US [patent_app_date] => 1993-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17092 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 390 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/283/05283230.pdf [firstpage_image] =>[orig_patent_app_number] => 036120 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3455009 [patent_doc_number] => 05378717 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-01-03 [patent_title] => 'Therapy for diabetic complications' [patent_app_type] => 1 [patent_app_number] => 8/034059 [patent_app_country] => US [patent_app_date] => 1993-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6676 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 216 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/378/05378717.pdf [firstpage_image] =>[orig_patent_app_number] => 034059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3422926 [patent_doc_number] => 05389631 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-02-14 [patent_title] => 'Fibrinogen receptor antagonists' [patent_app_type] => 1 [patent_app_number] => 8/034042 [patent_app_country] => US [patent_app_date] => 1993-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21412 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 765 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/389/05389631.pdf [firstpage_image] =>[orig_patent_app_number] => 034042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3099249 [patent_doc_number] => 05314895 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-05-24 [patent_title] => 'Benzopyran class III antiarrhythmic agents' [patent_app_type] => 1 [patent_app_number] => 8/029728 [patent_app_country] => US [patent_app_date] => 1993-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4721 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/314/05314895.pdf [firstpage_image] =>[orig_patent_app_number] => 029728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3454055 [patent_doc_number] => 05451603 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-09-19 [patent_title] => '3,4-diarylchromans for treatment of dermatitis' [patent_app_type] => 1 [patent_app_number] => 8/029739 [patent_app_country] => US [patent_app_date] => 1993-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2548 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/451/05451603.pdf [firstpage_image] =>[orig_patent_app_number] => 029739 [rel_patent_id] =>[rel_patent_doc_number] =>)